世界の泌尿生殖器がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Genitourinary Cancers Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5753
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、泌尿生殖器がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、がんクリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・泌尿生殖器がん治療の市場動向
・企業の競争状況、市場シェア
・泌尿生殖器がん治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、その他）
・泌尿生殖器がん治療の用途別市場規模と予測2016-2027（病院、がんクリニック、その他）
・泌尿生殖器がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・泌尿生殖器がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・泌尿生殖器がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・泌尿生殖器がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・泌尿生殖器がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche Holding、Celgene、Novartis、Bristol-Myers Squibb、Johnson & Johnson、Pfizer、Merck & Company、AbbVie、AstraZeneca、Eli Lilly）
・結論

Genitourinary cancers treatment pertains to the drugs used to cure or halt progress of cancers found in the urinary and the reproductive system, which include prostate cancer, kidney cancer, bladder cancer, testicular cancer and cancers of the penis. Genitourinary cancers treatment is a specialised branch of oncology that deals with the urinary and the reproductive systems.

Market Analysis and Insights: Global Genitourinary Cancers Treatment Market
The global Genitourinary Cancers Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genitourinary Cancers Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genitourinary Cancers Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genitourinary Cancers Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genitourinary Cancers Treatment market.

Global Genitourinary Cancers Treatment Scope and Market Size
Genitourinary Cancers Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genitourinary Cancers Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiotherapy
Others

Segment by Application
Hospitals
Cancer Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche Holding
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Pfizer
Merck & Company
AbbVie
AstraZeneca
Eli Lilly

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genitourinary Cancers Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Genitourinary Cancers Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Genitourinary Cancers Treatment Market Perspective (2016-2027)
2.2 Genitourinary Cancers Treatment Growth Trends by Regions
2.2.1 Genitourinary Cancers Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Genitourinary Cancers Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Genitourinary Cancers Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Genitourinary Cancers Treatment Industry Dynamic
2.3.1 Genitourinary Cancers Treatment Market Trends
2.3.2 Genitourinary Cancers Treatment Market Drivers
2.3.3 Genitourinary Cancers Treatment Market Challenges
2.3.4 Genitourinary Cancers Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Genitourinary Cancers Treatment Players by Revenue
3.1.1 Global Top Genitourinary Cancers Treatment Players by Revenue (2016-2021)
3.1.2 Global Genitourinary Cancers Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Genitourinary Cancers Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Genitourinary Cancers Treatment Revenue
3.4 Global Genitourinary Cancers Treatment Market Concentration Ratio
3.4.1 Global Genitourinary Cancers Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genitourinary Cancers Treatment Revenue in 2020
3.5 Genitourinary Cancers Treatment Key Players Head office and Area Served
3.6 Key Players Genitourinary Cancers Treatment Product Solution and Service
3.7 Date of Enter into Genitourinary Cancers Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Genitourinary Cancers Treatment Breakdown Data by Type
4.1 Global Genitourinary Cancers Treatment Historic Market Size by Type (2016-2021)
4.2 Global Genitourinary Cancers Treatment Forecasted Market Size by Type (2022-2027)

5 Genitourinary Cancers Treatment Breakdown Data by Application
5.1 Global Genitourinary Cancers Treatment Historic Market Size by Application (2016-2021)
5.2 Global Genitourinary Cancers Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Genitourinary Cancers Treatment Market Size (2016-2027)
6.2 North America Genitourinary Cancers Treatment Market Size by Type
6.2.1 North America Genitourinary Cancers Treatment Market Size by Type (2016-2021)
6.2.2 North America Genitourinary Cancers Treatment Market Size by Type (2022-2027)
6.2.3 North America Genitourinary Cancers Treatment Market Size by Type (2016-2027)
6.3 North America Genitourinary Cancers Treatment Market Size by Application
6.3.1 North America Genitourinary Cancers Treatment Market Size by Application (2016-2021)
6.3.2 North America Genitourinary Cancers Treatment Market Size by Application (2022-2027)
6.3.3 North America Genitourinary Cancers Treatment Market Size by Application (2016-2027)
6.4 North America Genitourinary Cancers Treatment Market Size by Country
6.4.1 North America Genitourinary Cancers Treatment Market Size by Country (2016-2021)
6.4.2 North America Genitourinary Cancers Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Genitourinary Cancers Treatment Market Size (2016-2027)
7.2 Europe Genitourinary Cancers Treatment Market Size by Type
7.2.1 Europe Genitourinary Cancers Treatment Market Size by Type (2016-2021)
7.2.2 Europe Genitourinary Cancers Treatment Market Size by Type (2022-2027)
7.2.3 Europe Genitourinary Cancers Treatment Market Size by Type (2016-2027)
7.3 Europe Genitourinary Cancers Treatment Market Size by Application
7.3.1 Europe Genitourinary Cancers Treatment Market Size by Application (2016-2021)
7.3.2 Europe Genitourinary Cancers Treatment Market Size by Application (2022-2027)
7.3.3 Europe Genitourinary Cancers Treatment Market Size by Application (2016-2027)
7.4 Europe Genitourinary Cancers Treatment Market Size by Country
7.4.1 Europe Genitourinary Cancers Treatment Market Size by Country (2016-2021)
7.4.2 Europe Genitourinary Cancers Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Genitourinary Cancers Treatment Market Size (2016-2027)
8.2 Asia-Pacific Genitourinary Cancers Treatment Market Size by Type
8.2.1 Asia-Pacific Genitourinary Cancers Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Genitourinary Cancers Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Genitourinary Cancers Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Genitourinary Cancers Treatment Market Size by Application
8.3.1 Asia-Pacific Genitourinary Cancers Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Genitourinary Cancers Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Genitourinary Cancers Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Genitourinary Cancers Treatment Market Size by Region
8.4.1 Asia-Pacific Genitourinary Cancers Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Genitourinary Cancers Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Genitourinary Cancers Treatment Market Size (2016-2027)
9.2 Latin America Genitourinary Cancers Treatment Market Size by Type
9.2.1 Latin America Genitourinary Cancers Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Genitourinary Cancers Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Genitourinary Cancers Treatment Market Size by Type (2016-2027)
9.3 Latin America Genitourinary Cancers Treatment Market Size by Application
9.3.1 Latin America Genitourinary Cancers Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Genitourinary Cancers Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Genitourinary Cancers Treatment Market Size by Application (2016-2027)
9.4 Latin America Genitourinary Cancers Treatment Market Size by Country
9.4.1 Latin America Genitourinary Cancers Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Genitourinary Cancers Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Genitourinary Cancers Treatment Market Size (2016-2027)
10.2 Middle East & Africa Genitourinary Cancers Treatment Market Size by Type
10.2.1 Middle East & Africa Genitourinary Cancers Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Genitourinary Cancers Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Genitourinary Cancers Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Genitourinary Cancers Treatment Market Size by Application
10.3.1 Middle East & Africa Genitourinary Cancers Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Genitourinary Cancers Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Genitourinary Cancers Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Genitourinary Cancers Treatment Market Size by Country
10.4.1 Middle East & Africa Genitourinary Cancers Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Genitourinary Cancers Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche Holding
11.1.1 Roche Holding Company Details
11.1.2 Roche Holding Business Overview
11.1.3 Roche Holding Genitourinary Cancers Treatment Introduction
11.1.4 Roche Holding Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.1.5 Roche Holding Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Genitourinary Cancers Treatment Introduction
11.2.4 Celgene Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.2.5 Celgene Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Genitourinary Cancers Treatment Introduction
11.3.4 Novartis Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Genitourinary Cancers Treatment Introduction
11.4.4 Bristol-Myers Squibb Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Genitourinary Cancers Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Genitourinary Cancers Treatment Introduction
11.6.4 Pfizer Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Merck & Company
11.7.1 Merck & Company Company Details
11.7.2 Merck & Company Business Overview
11.7.3 Merck & Company Genitourinary Cancers Treatment Introduction
11.7.4 Merck & Company Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.7.5 Merck & Company Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Genitourinary Cancers Treatment Introduction
11.8.4 AbbVie Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Genitourinary Cancers Treatment Introduction
11.9.4 AstraZeneca Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Genitourinary Cancers Treatment Introduction
11.10.4 Eli Lilly Revenue in Genitourinary Cancers Treatment Business (2016-2021)
11.10.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Genitourinary Cancers Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Others
Table 5. Global Genitourinary Cancers Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Genitourinary Cancers Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Genitourinary Cancers Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Genitourinary Cancers Treatment Market Share by Regions (2016-2021)
Table 9. Global Genitourinary Cancers Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Genitourinary Cancers Treatment Market Share by Regions (2022-2027)
Table 11. Genitourinary Cancers Treatment Market Trends
Table 12. Genitourinary Cancers Treatment Market Drivers
Table 13. Genitourinary Cancers Treatment Market Challenges
Table 14. Genitourinary Cancers Treatment Market Restraints
Table 15. Global Genitourinary Cancers Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Genitourinary Cancers Treatment Market Share by Players (2016-2021)
Table 17. Global Top Genitourinary Cancers Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Cancers Treatment as of 2020)
Table 18. Ranking of Global Top Genitourinary Cancers Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Genitourinary Cancers Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genitourinary Cancers Treatment Product Solution and Service
Table 22. Date of Enter into Genitourinary Cancers Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genitourinary Cancers Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Genitourinary Cancers Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Genitourinary Cancers Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Genitourinary Cancers Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Genitourinary Cancers Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Genitourinary Cancers Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Genitourinary Cancers Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Genitourinary Cancers Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Genitourinary Cancers Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Genitourinary Cancers Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Genitourinary Cancers Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Genitourinary Cancers Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Genitourinary Cancers Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Genitourinary Cancers Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Genitourinary Cancers Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Genitourinary Cancers Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Genitourinary Cancers Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Genitourinary Cancers Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Genitourinary Cancers Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Genitourinary Cancers Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Genitourinary Cancers Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Genitourinary Cancers Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Genitourinary Cancers Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Genitourinary Cancers Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Genitourinary Cancers Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Genitourinary Cancers Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Genitourinary Cancers Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Genitourinary Cancers Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Genitourinary Cancers Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Genitourinary Cancers Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Genitourinary Cancers Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Genitourinary Cancers Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Genitourinary Cancers Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Genitourinary Cancers Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Genitourinary Cancers Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Genitourinary Cancers Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Genitourinary Cancers Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Genitourinary Cancers Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Holding Company Details
Table 63. Roche Holding Business Overview
Table 64. Roche Holding Genitourinary Cancers Treatment Product
Table 65. Roche Holding Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 66. Roche Holding Recent Development
Table 67. Celgene Company Details
Table 68. Celgene Business Overview
Table 69. Celgene Genitourinary Cancers Treatment Product
Table 70. Celgene Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 71. Celgene Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Genitourinary Cancers Treatment Product
Table 75. Novartis Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Genitourinary Cancers Treatment Product
Table 80. Bristol-Myers Squibb Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Genitourinary Cancers Treatment Product
Table 85. Johnson & Johnson Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Genitourinary Cancers Treatment Product
Table 90. Pfizer Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Merck & Company Company Details
Table 93. Merck & Company Business Overview
Table 94. Merck & Company Genitourinary Cancers Treatment Product
Table 95. Merck & Company Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 96. Merck & Company Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 100. AbbVie Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Genitourinary Cancers Treatment Product
Table 104. AstraZeneca Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Genitourinary Cancers Treatment Product
Table 109. Eli Lilly Revenue in Genitourinary Cancers Treatment Business (2016-2021) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genitourinary Cancers Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Others Features
Figure 5. Global Genitourinary Cancers Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Cancer Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Genitourinary Cancers Treatment Report Years Considered
Figure 10. Global Genitourinary Cancers Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Genitourinary Cancers Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Genitourinary Cancers Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Genitourinary Cancers Treatment Market Share by Regions (2022-2027)
Figure 14. Global Genitourinary Cancers Treatment Market Share by Players in 2020
Figure 15. Global Top Genitourinary Cancers Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genitourinary Cancers Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Genitourinary Cancers Treatment Revenue in 2020
Figure 17. Global Genitourinary Cancers Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Genitourinary Cancers Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Genitourinary Cancers Treatment Market Share by Type (2016-2027)
Figure 21. North America Genitourinary Cancers Treatment Market Share by Application (2016-2027)
Figure 22. North America Genitourinary Cancers Treatment Market Share by Country (2016-2027)
Figure 23. United States Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Genitourinary Cancers Treatment Market Share by Type (2016-2027)
Figure 27. Europe Genitourinary Cancers Treatment Market Share by Application (2016-2027)
Figure 28. Europe Genitourinary Cancers Treatment Market Share by Country (2016-2027)
Figure 29. Germany Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Genitourinary Cancers Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Genitourinary Cancers Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Genitourinary Cancers Treatment Market Share by Region (2016-2027)
Figure 39. China Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Genitourinary Cancers Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Genitourinary Cancers Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Genitourinary Cancers Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Genitourinary Cancers Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Genitourinary Cancers Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Genitourinary Cancers Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Genitourinary Cancers Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Holding Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 59. Celgene Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 64. Merck & Company Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 65. AbbVie Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 66. AstraZeneca Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Genitourinary Cancers Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の泌尿生殖器系治療市場規模・現状・予測（2021年-2027年）

Global Genitourinary System Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5754 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、泌尿生殖器系治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南ア...

世界の婦人科がん治療薬市場規模・現状・予測（2021年-2027年）

Global Gynecological Cancers Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5764 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、婦人科がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（子宮頸がん、卵巣がん、子宮内膜がん、膣がん、外陰がん、その他）、用途別市場規模（標的療法、化学療法）、主要地域別市場規模（北米、アメリカ...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の泌尿生殖器系治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Genitourinary System Treatment Market The global Genitourinary System Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界の婦人科がん治療薬市場規模・現状・予測（2021年-2027年） Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer. The presence o…
婦人科癌治療薬のグローバル市場：規模・現状・予測2019-2025 Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.The presence of…
婦人科癌治療薬のグローバル市場：規模・現状・予測2019-2025 Gynecological Cancers Therapeutics refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.The presence of…
血液癌のグローバル市場調査 2019年 The global Hematological Cancers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hematological Cancers volume and value at global level, regional level and company level. From a global perspective, …